Listed

Enveric Biosciences, Inc.: Form 10-Q for the period ended Sep 30, 2016

Filed with the SEC on Nov 14, 2016 and accepted by EDGAR at Nov 14, 2016, 16:48 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-07-01 to 2016-09-30$10.1mus-gaap:SalesRevenueNet
Revenue9 months2016-01-01 to 2016-09-30$23.8mus-gaap:SalesRevenueNet
Cost of revenue3 months2016-07-01 to 2016-09-30$8.4mus-gaap:CostOfRevenue
Cost of revenue9 months2016-01-01 to 2016-09-30$19.3mus-gaap:CostOfRevenue
Gross profit3 months2016-07-01 to 2016-09-30$1.7mus-gaap:GrossProfit
Gross profit9 months2016-01-01 to 2016-09-30$4.5mus-gaap:GrossProfit
Operating income3 months2016-07-01 to 2016-09-30−$1.3mus-gaap:OperatingIncomeLoss
Operating income9 months2016-01-01 to 2016-09-30−$3.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2016-07-01 to 2016-09-30$290.4kus-gaap:InterestExpense
Interest expense9 months2016-01-01 to 2016-09-30$674.7kus-gaap:InterestExpense
Net income3 months2016-07-01 to 2016-09-30−$1.7mus-gaap:NetIncomeLoss
Net income9 months2016-01-01 to 2016-09-30−$4.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-07-01 to 2016-09-30−$0.13us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2016-01-01 to 2016-09-30−$0.32us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-07-01 to 2016-09-30−$0.13us-gaap:EarningsPerShareBasic
Basic EPS9 months2016-01-01 to 2016-09-30−$0.32us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-07-01 to 2016-09-3013,653,586 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2016-01-01 to 2016-09-3012,794,149 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2016-01-01 to 2016-09-30−$3.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2016-09-30$2.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-09-30$11.3mus-gaap:AssetsCurrent
Total assetsAt period end2016-09-30$38.1mus-gaap:Assets
Current liabilitiesAt period end2016-09-30$13.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-09-30$33.4mus-gaap:Liabilities
Long-term debtAt period end2016-09-30$1.6mus-gaap:LongTermDebt
Shareholders' equityAt period end2016-09-30$4.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001079974-16-001683. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.